SeungJin Bae

1.4k total citations
71 papers, 869 citations indexed

About

SeungJin Bae is a scholar working on Economics and Econometrics, Small Animals and Immunology. According to data from OpenAlex, SeungJin Bae has authored 71 papers receiving a total of 869 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Economics and Econometrics, 13 papers in Small Animals and 10 papers in Immunology. Recurrent topics in SeungJin Bae's work include Health Systems, Economic Evaluations, Quality of Life (25 papers), Pharmaceutical Economics and Policy (22 papers) and Animal testing and alternatives (12 papers). SeungJin Bae is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (25 papers), Pharmaceutical Economics and Policy (22 papers) and Animal testing and alternatives (12 papers). SeungJin Bae collaborates with scholars based in South Korea, Japan and United States. SeungJin Bae's co-authors include Kyung‐Min Lim, Dong‐Sook Kim, Eun Young Bae, Hye-Young Kwon, Kyung‐Bok Son, Nayoung Kim, Sung Woo Jung, Ki‐Nam Shim, Meredith B. Rosenthal and Yu Kyung Cho and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Allergy and Clinical Immunology and Annals of Oncology.

In The Last Decade

SeungJin Bae

65 papers receiving 843 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
SeungJin Bae South Korea 17 245 114 107 98 88 71 869
Mohamad Raad United States 14 50 0.2× 47 0.4× 43 0.4× 25 0.3× 83 0.9× 30 849
Claire Jenkinson United Kingdom 17 229 0.9× 119 1.0× 79 0.7× 6 0.1× 80 0.9× 17 906
Ranjeeta Kumari India 15 70 0.3× 38 0.3× 25 0.2× 44 0.4× 69 0.8× 86 795
David J Margolis United States 5 69 0.3× 41 0.4× 74 0.7× 10 0.1× 176 2.0× 7 830
Irbaz Hameed United States 19 40 0.2× 436 3.8× 40 0.4× 22 0.2× 141 1.6× 101 1.2k
Zahra Cheraghi Iran 15 34 0.1× 165 1.4× 32 0.3× 39 0.4× 154 1.8× 52 1000
Srikesh Arunajadai United States 12 41 0.2× 42 0.4× 26 0.2× 17 0.2× 95 1.1× 26 1.2k
Jean-Bernard Gillet Belgium 11 71 0.3× 75 0.7× 26 0.2× 9 0.1× 111 1.3× 27 963
Caren Heller United States 13 128 0.5× 211 1.9× 70 0.7× 4 0.0× 242 2.8× 32 1.1k
Erica Brittain United States 26 217 0.9× 141 1.2× 582 5.4× 8 0.1× 80 0.9× 59 2.3k

Countries citing papers authored by SeungJin Bae

Since Specialization
Citations

This map shows the geographic impact of SeungJin Bae's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SeungJin Bae with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SeungJin Bae more than expected).

Fields of papers citing papers by SeungJin Bae

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by SeungJin Bae. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SeungJin Bae. The network helps show where SeungJin Bae may publish in the future.

Co-authorship network of co-authors of SeungJin Bae

This figure shows the co-authorship network connecting the top 25 collaborators of SeungJin Bae. A scholar is included among the top collaborators of SeungJin Bae based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with SeungJin Bae. SeungJin Bae is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
3.
Ha, Hyerim, et al.. (2022). The value measurement of emerging therapeutics in renal cell carcinoma: ASCO value framework and ESMO-MCBS. BMC Health Services Research. 22(1). 900–900. 3 indexed citations
4.
Bae, SeungJin, et al.. (2022). How Sensitive is Sensitivity Analysis?: Evaluation of Pharmacoeconomic Submissions in Korea. Frontiers in Pharmacology. 13. 884769–884769. 4 indexed citations
5.
Kim, Do Yeun, Hyerim Ha, SeungJin Bae, & Jin Hyoung Kang. (2021). Should We Consider Value Frameworks for Cancer Drugs as Oncology's Landscape Evolves?; from an Oncologist Perspective in Korea. Journal of Korean Medical Science. 36(29). e191–e191. 1 indexed citations
6.
Kim, Dong‐Sook, et al.. (2021). Regenerative Medicine in South Korea: Bridging the Gap Between Authorization and Reimbursement. Frontiers in Bioengineering and Biotechnology. 9. 737504–737504. 6 indexed citations
7.
Bae, SeungJin, Hyun‐Jin Choi, Kyung‐Bok Son, et al.. (2021). How can we improve patients’ access to new drugs under uncertainties? : South Korea’s experience with risk sharing arrangements. BMC Health Services Research. 21(1). 967–967. 9 indexed citations
8.
Choi, Inseon S., et al.. (2020). PCN352 THE BURDEN OF HUMAN PAPILLOMAVIRUS-RELATED CERVICAL DISEASES IN KOREA: A POPULATION-BASED STUDY. Value in Health. 23. S86–S86. 1 indexed citations
9.
Choi, Inseon S., Donghwan Lee, Kyung‐Bok Son, & SeungJin Bae. (2020). Incidence, cost and gender differences of oropharyngeal and noncervical anogenital cancers in South Korea. BMC Public Health. 20(1). 1035–1035. 10 indexed citations
10.
Son, Kyung‐Bok & SeungJin Bae. (2019). Patterns of statin utilisation for new users and market dynamics in South Korea: a 13-year retrospective cohort study. BMJ Open. 9(3). e026603–e026603. 14 indexed citations
12.
Choi, Dalwoong, et al.. (2017). Modeling lifetime costs and health outcomes attributable to secondhand smoke exposure at home among Korean adult women. BMJ Open. 7(5). e013292–e013292. 8 indexed citations
13.
Yun, Jun-Won, Yirang Na, Byeong-Cheol Kang, et al.. (2016). Exploration and comparison of in vitro eye irritation tests with the ISO standard in vivo rabbit test for the evaluation of the ocular irritancy of contact lenses. Toxicology in Vitro. 37. 79–87. 10 indexed citations
14.
Kim, Da-eun, Won-Hee Jang, Susun An, et al.. (2016). Prevalidation trial for a novel in vitro eye irritation test using the reconstructed human cornea-like epithelial model, MCTT HCE™. Toxicology in Vitro. 39. 58–67. 17 indexed citations
15.
Bae, SeungJin, et al.. (2015). Ethical issues in allocating health care resource for severely ill patients. 21(1). 125–148. 1 indexed citations
17.
Bae, SeungJin, et al.. (2014). Analysis of Statistical Methods Currently used in Toxicology Journals. Toxicological Research. 30(3). 185–191. 8 indexed citations
18.
Kim, Min Jeong, SeungJin Bae, & Kyung‐Min Lim. (2013). Impact of High Fat Diet-induced Obesity on the Plasma Levels of Monoamine Neurotransmitters in C57BL/6 Mice. Biomolecules & Therapeutics. 21(6). 476–480. 28 indexed citations
19.
Cho, Yu Kyung, SeungJin Bae, Dong‐Sook Kim, et al.. (2011). Prevalence of gastroesophageal reflux disease in Korea and associated health‐care utilization: A national population‐based study. Journal of Gastroenterology and Hepatology. 27(4). 741–745. 57 indexed citations
20.
Fuhlbrigge, Anne L., SeungJin Bae, Scott T. Weiss, Karen M. Kuntz, & A. David Paltiel. (2006). Cost-effectiveness of inhaled steroids in asthma: Impact of effect on bone mineral density. Journal of Allergy and Clinical Immunology. 117(2). 359–366. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026